Fig. 1From: Increased serum IL-36γ levels are associated with disease severity in myasthenia gravis patientsSerum IL-36γ levels in myasthenia gravis (MG) patients and healthy controls (HCs). a Comparison of serum IL-36γ levels among MG patients, generalized MG (GMG) patients, ocular MG (OMG) patients and HCs. b Comparison of serum IL-36γ levels among severe MG patients, mild MG patients and HCsBack to article page